Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion type Assertion NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_head.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion description "[We analyzed TMPRSS2-ERG gene rearrangement status by fluorescence in situ hybridization in 521 cases of clinically localized surgically treated prostate cancer with 95 months of median follow-up and also in 40 unmatched metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_provenance.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion evidence source_evidence_literature NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_provenance.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion SIO_000772 19190343 NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_provenance.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion wasDerivedFrom befree-20140225 NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_provenance.
- NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_assertion wasGeneratedBy ECO_0000203 NP501641.RAWr5ZvXg7vJ8EpqHkNKTwnyBHfZCyb7iO2Qu0VbEsWQA130_provenance.